
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD
Hong Liu, Suryasarathi Dasgupta, Yu Fu, et al.
BMC Immunology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 56
Hong Liu, Suryasarathi Dasgupta, Yu Fu, et al.
BMC Immunology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
Renaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Gut (2018) Vol. 68, Iss. 4, pp. 604-614
Open Access | Times Cited: 176
Renaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Gut (2018) Vol. 68, Iss. 4, pp. 604-614
Open Access | Times Cited: 176
Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
Ángela Saéz, Raquel Gómez-Bris, Beatriz Herrero‐Fernández, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7618-7618
Open Access | Times Cited: 135
Ángela Saéz, Raquel Gómez-Bris, Beatriz Herrero‐Fernández, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7618-7618
Open Access | Times Cited: 135
The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects
C.-L. Li, Kaixin Peng, Siqi Xiao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 67
C.-L. Li, Kaixin Peng, Siqi Xiao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?
Lei Li, Peilan Peng, Ning Ding, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 967-967
Open Access | Times Cited: 64
Lei Li, Peilan Peng, Ning Ding, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 967-967
Open Access | Times Cited: 64
Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
Amandip Kaur, Paraskevi Goggolidou
Journal of Inflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 117
Amandip Kaur, Paraskevi Goggolidou
Journal of Inflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 117
Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease
Friederike Cordes, Dirk Foell, Nik S. Ding, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 28, pp. 4055-4075
Open Access | Times Cited: 73
Friederike Cordes, Dirk Foell, Nik S. Ding, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 28, pp. 4055-4075
Open Access | Times Cited: 73
A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals
Ke Wang, Tangyou Mao, Xinyu Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Ke Wang, Tangyou Mao, Xinyu Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
Marek Vébr, Renata Pomahačová, Josef Sýkora, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3229-3229
Open Access | Times Cited: 25
Marek Vébr, Renata Pomahačová, Josef Sýkora, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3229-3229
Open Access | Times Cited: 25
Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study
Mostafa M. Bahaa, Sahar K. Hegazy, M Maher, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3247-3258
Closed Access | Times Cited: 9
Mostafa M. Bahaa, Sahar K. Hegazy, M Maher, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3247-3258
Closed Access | Times Cited: 9
Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution
Charlène Trilleaud, Vanessa Gauttier, Kévin Biteau, et al.
Science Advances (2021) Vol. 7, Iss. 14
Closed Access | Times Cited: 52
Charlène Trilleaud, Vanessa Gauttier, Kévin Biteau, et al.
Science Advances (2021) Vol. 7, Iss. 14
Closed Access | Times Cited: 52
Update: Innate Lymphoid Cells in Inflammatory Bowel Disease
Weiwei Luo, Li Tian, Bei Tan, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 1, pp. 56-66
Closed Access | Times Cited: 46
Weiwei Luo, Li Tian, Bei Tan, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 1, pp. 56-66
Closed Access | Times Cited: 46
Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease
Omayra Martin-Rodriguez, Thierry Gauthier, Francis Bonnefoy, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
Omayra Martin-Rodriguez, Thierry Gauthier, Francis Bonnefoy, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases
Hui Cao, Jun Diao, Huosheng Liu, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 5, pp. 818-829
Closed Access | Times Cited: 37
Hui Cao, Jun Diao, Huosheng Liu, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 5, pp. 818-829
Closed Access | Times Cited: 37
Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease
Shixian Hu, Werna T. Uniken Venema, Harm-Jan Westra, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Shixian Hu, Werna T. Uniken Venema, Harm-Jan Westra, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Role of a probiotic strain in the modulation of gut microbiota and cytokines in inflammatory bowel disease
V Deepak Bamola, Divya Dubey, Projoyita Samanta, et al.
Anaerobe (2022) Vol. 78, pp. 102652-102652
Open Access | Times Cited: 25
V Deepak Bamola, Divya Dubey, Projoyita Samanta, et al.
Anaerobe (2022) Vol. 78, pp. 102652-102652
Open Access | Times Cited: 25
Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
Yuxuan Xia, Zhang Li, Dickson Kofi Wiredu Ocansey, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Yuxuan Xia, Zhang Li, Dickson Kofi Wiredu Ocansey, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Formononetin ameliorates dextran sulfate sodium-induced colitis via enhancing antioxidant capacity, promoting tight junction protein expression and reshaping M1/M2 macrophage polarization balance
Qiuping Xiao, Jiaqi Huang, Xiyan Zhu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113174-113174
Closed Access | Times Cited: 5
Qiuping Xiao, Jiaqi Huang, Xiyan Zhu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113174-113174
Closed Access | Times Cited: 5
M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
Jiaxi Lu, Deliang Liu, Yuyong Tan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 3041-3050
Open Access | Times Cited: 32
Jiaxi Lu, Deliang Liu, Yuyong Tan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 3041-3050
Open Access | Times Cited: 32
Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease
Vanessa Zaiatz-Bittencourt, Fiona Jones, Glen Doherty, et al.
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. 10, pp. 1684-1693
Open Access | Times Cited: 29
Vanessa Zaiatz-Bittencourt, Fiona Jones, Glen Doherty, et al.
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. 10, pp. 1684-1693
Open Access | Times Cited: 29
Adipose-Derived Mesenchymal Stem Cells Reprogram M1 Macrophage Metabolism via PHD2/HIF-1α Pathway in Colitis Mice
Yin Yuan, Shuo Ni, Aoxiang Zhuge, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Yin Yuan, Shuo Ni, Aoxiang Zhuge, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases
Mohamad Karaky, Gabrielle Boucher, Saraï Mola, et al.
PLoS Genetics (2022) Vol. 18, Iss. 9, pp. e1010189-e1010189
Open Access | Times Cited: 21
Mohamad Karaky, Gabrielle Boucher, Saraï Mola, et al.
PLoS Genetics (2022) Vol. 18, Iss. 9, pp. e1010189-e1010189
Open Access | Times Cited: 21
The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases
Fei Zou, Su Wang, Mengmeng Xu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Fei Zou, Su Wang, Mengmeng Xu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Dynamic regulatory elements in single-cell multimodal data implicate key immune cell states enriched for autoimmune disease heritability
Anika Gupta, Kathryn Weinand, Aparna Nathan, et al.
Nature Genetics (2023) Vol. 55, Iss. 12, pp. 2200-2210
Open Access | Times Cited: 11
Anika Gupta, Kathryn Weinand, Aparna Nathan, et al.
Nature Genetics (2023) Vol. 55, Iss. 12, pp. 2200-2210
Open Access | Times Cited: 11
Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight
Fares E.M. Ali, Mohamed Elfiky, Walaa A. Fadda, et al.
Life Sciences (2021) Vol. 276, pp. 119433-119433
Closed Access | Times Cited: 22
Fares E.M. Ali, Mohamed Elfiky, Walaa A. Fadda, et al.
Life Sciences (2021) Vol. 276, pp. 119433-119433
Closed Access | Times Cited: 22
Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy
Harrison M. Penrose, Rida Iftikhar, Morgan E. Collins, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Harrison M. Penrose, Rida Iftikhar, Morgan E. Collins, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22